Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03469349
Brief Title: Actovegin 12-Week Treatment Given First Intravenously and Subsequently Orally in Participants With Peripheral Arterial Occlusive Disease Fontaine Stage IIB (APOLLO)

First Submitted : March 13, 2018
First Submitted that Met QC Criteria : March 13, 2018
First Posted : March 19, 2018

Last Update Submitted that Met QC Criteria : August 21, 2019
Last Update Posted : August 22, 2019